SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-22
👔
Definium Therapeutics, Inc.
@DFTX_InsiderForm 4 Filing: Roberts Brandi Acquires (Grant) shares of $DFTX
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Definium Therapeutics, Inc.
Ticker: $DFTX
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-22
Shares: 62,500
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Roberts Brandi, holds the title of Chief Financial Officer at Definium Therapeutics, Inc..
On 2026-06-22, the insider transacted 62,500 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Roberts Brandi (Chief Financial Officer) was granted $0 of $DFTX
Post-Transaction Position: 212,500 shares
SEC Accession No: 0001193125-26-276880 (CIK: 1516354)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.